Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
---|
08/01/2012 | CN102266510B Chinese medicinal composition for treating cervical spondylosis by matching super micro knife |
08/01/2012 | CN101947155B Electric hot water bag with Chinese herbal medicine solution for treating arthritis and functions of massage and temperature control |
08/01/2012 | CN101912539B Chinese medicinal composition for treating cervical spondylotic radiculopathy and preparation method thereof |
08/01/2012 | CN101773539B Prescription with function for mitigating and curing osteoarthrosis |
08/01/2012 | CN101507758B Traditional Chinese medicine combination |
07/31/2012 | US8232383 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
07/31/2012 | US8232286 N-[1-(3-dimethylamino-4-formyl-phenyl)-3-pyridin-3-yl-4,5-dihydro-1H-pyrazolo[4,3-g]benzothiazol-7-yl]-acetamide; phosphatidylinositol-3-kinases (PI3-kinases) inhibitor; cell growth, differentiation and intracellular transport processes; antiproliferative, antiinflammatory agent; autoimmune diseases |
07/31/2012 | US8232260 In vivo production of small interfering RNAs that mediate gene silencing |
07/31/2012 | US8232258 NK1 fragment of hepatocyte growth factor/scatter factor (HGF/SF) and variants thereof, and their use |
07/31/2012 | US8232068 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays |
07/31/2012 | US8231873 Methods of treatment using antibodies to Neutrokine-alpha |
07/31/2012 | US8231856 Chlorite formulations and methods of preparation and use thereof |
07/31/2012 | CA2471656C Antibody against fibroblast growth factor-23 |
07/31/2012 | CA2465375C 2-aryl-propionic acids and pharmaceutical compositions containing them |
07/31/2012 | CA2370948C Growth factor homolog zvegf4 |
07/31/2012 | CA2341018C Polypeptides and polynucleotides from coagulase-negative staphylococci |
07/26/2012 | WO2012100050A1 A composition for the attachment of implants to collagen or other components of biological tissue |
07/26/2012 | WO2012098501A1 Febuxostat co-crystals |
07/26/2012 | WO2012098387A1 6, 7-ring-fused triazolo [4, 3 - b] pyridazine derivatives as pim inhibitors |
07/26/2012 | US20120190821 Recombinant soluble fc receptors |
07/26/2012 | US20120190751 Compounds for treatments of inflammation |
07/26/2012 | US20120190727 Method and means for treatment of osteoarthritis |
07/26/2012 | US20120190699 Pyridones useful as inhibitors of kinases |
07/26/2012 | US20120190689 Piperazinyl 3-aminopyrrolidine derivatives as a ccr2 antagonist |
07/26/2012 | US20120190680 Heteroaryl Amide Analogues |
07/26/2012 | US20120190678 Substituted pyrazolo-quinazoline derivatives as kinase inhibitors |
07/26/2012 | US20120190665 Pyrazolopyrimidine jak inhibitor compounds and methods |
07/26/2012 | US20120190651 Anti-inflammatory compounds |
07/26/2012 | US20120190650 Inhibitors of Autotaxin |
07/26/2012 | US20120190649 Bicyclic aryl sphingosine 1-phosphate analogs |
07/26/2012 | US20120190647 Novel oral forms of a phosphonic acid derivative |
07/26/2012 | US20120190639 Treatment or prophylaxis of proliferative conditions |
07/26/2012 | US20120190634 Lipoteichoic acid-derived glycolipids, and compositions comprising same |
07/26/2012 | US20120190625 Novel peptide and use thereof |
07/26/2012 | US20120190616 Analogues of Insulin-Like Growth Factor-1 (IGF-1) Having Amino Acid Substitution at Position 59 |
07/26/2012 | US20120190612 Methods of treatment |
07/26/2012 | US20120189717 Method of using beta-hydroxy-beta-methylbutyrate and fatty acids for treating disease-associated wasting |
07/26/2012 | US20120189716 Method of using beta-hydroxy-beta-methylbutyrate for treating disease-associated wasting |
07/26/2012 | US20120189715 Compositions including beta-hydroxy-beta-methylbutyrate and uses thereof |
07/26/2012 | US20120189714 Compositions including beta-hydroxy-beta-methylbutyrate |
07/26/2012 | US20120189704 Novel injectable chitosan mixtures forming hydrogels |
07/26/2012 | US20120189694 Co-precipitate comprising a phosphodiesterase-5 inhibitor (pde-5-inhibitor) and a pharmaceutically compatible carrier, production and use thereof |
07/26/2012 | US20120189693 Oral dosage forms |
07/26/2012 | US20120189690 Liposomes covered with the Extracellular Domain of the APO2L/Trail Protein |
07/26/2012 | US20120189683 Composite of amorphous calcium phosphate/calcium sulfate hemihydrate (csh/acp) for bone implantation and process for producing the same |
07/26/2012 | US20120189669 Solid Forms for Tissue Repair |
07/26/2012 | US20120189668 Hydrogel bioscaffold and coating for bone and tooth repair |
07/26/2012 | US20120189667 Method for repairing or replacing damaged tissue |
07/26/2012 | US20120189666 Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent |
07/26/2012 | US20120189626 Treatment of complement-associated disorders |
07/26/2012 | US20120189624 Treatment and prophylaxis of amyloidosis |
07/26/2012 | US20120189622 Anti-cd38 human antibodies and uses thereof |
07/26/2012 | US20120189621 Combination Therapies and Methods Using Anti-CD3 Modulating Agents and Anti-IL-6 Antagonists |
07/26/2012 | US20120189619 Methods for treating a spinal disorder or osteoarthritis using dominant negative tissue necrosis factor |
07/26/2012 | US20120189587 Cell sheet for tissue repair and bio-artificial tissue engineering, method of producing the same and method of using the same |
07/26/2012 | US20120189584 Genipin cross-linked fibrin gels |
07/26/2012 | US20120189558 Anti-bacterial compositions comprising extracts of eremophila longifolia and methods for use of same |
07/26/2012 | US20120189543 Compositions and Methods for Detecting and Treating Implant Loosening and Osteolysis |
07/26/2012 | US20120189541 Dual Variable Domain Immunnoglobulins and Uses Thereof |
07/25/2012 | EP2478923A1 Bone regeneration agent including gelatin |
07/25/2012 | EP2478909A2 Pharmaceutical compositions comprising bisphosphonate derivatives and high-dose cholecalciferol |
07/25/2012 | EP2477989A1 COMPOUNDS HAVING TAFIa INHIBITORY ACTIVITY |
07/25/2012 | EP2477618A2 Nutritional compositions including exogenous vitamin k2 |
07/25/2012 | EP2292611B1 Novel thiophenediamine derivative having urea structure |
07/25/2012 | EP1751175B1 Interleukin-1 receptor antagonists, compositions, and methods of treatment |
07/25/2012 | EP1711531B9 Neutralizing anti tlr4/md-2 antibodies and methods of use thereof |
07/25/2012 | EP1691814B1 Anti-inflammatory agents |
07/25/2012 | EP1333808B1 Electroprocessed composition used in drug delivery and cell encapsulation |
07/25/2012 | EP1322641B1 Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein junkinases |
07/25/2012 | EP1257544B1 Piperazine and piperidine derivatives for treatment or prevention of neuronal damage |
07/25/2012 | EP1252162B1 Alpha v integrin receptor antagonists |
07/25/2012 | CN102612524A Dual variable domain immunoglobulins and uses thereof |
07/25/2012 | CN102603894A Interferon alpha receptor 1 antibodies and their uses |
07/25/2012 | CN102603827A Paeoniflorin aromatic ester derivative, preparation method and applications thereof |
07/25/2012 | CN102603734A Protein kinase inhibitor and application thereof |
07/25/2012 | CN102603694A Novel synthesis method of murrayone and novel application of murrayone |
07/25/2012 | CN102603610A 1,3-dihydro-1-oxo-2H-isobenzazole compounds as well as preparation method and use thereof |
07/25/2012 | CN102603565A Compounds for treatment of cell proliferative diseases |
07/25/2012 | CN102600705A Edible plant dryer |
07/25/2012 | CN102600472A Dosage regimen of an s1p receptor agonist |
07/25/2012 | CN102600458A Compound preparation of glucosamine chondroitin and production method of compound preparation |
07/25/2012 | CN102600455A Remedy and therapeutic method for periodontal diseases and pulpal diseases |
07/25/2012 | CN102600434A Compound mixture for curing cervical vertigo |
07/25/2012 | CN102600430A Medicine for curing femoral head necrosis |
07/25/2012 | CN102600414A Chinese medicinal composition for treating cervical spondylosis |
07/25/2012 | CN102600413A Fumigated Chinese herbal medicine for treating neck, shoulder, waist and leg pains and preparation method thereof |
07/25/2012 | CN102600407A Medicinal composition for treating osteonecrosis after kidney transplantation |
07/25/2012 | CN102600404A Traditional Chinese medicine for treating undifferentiated spondyloarthropathy |
07/25/2012 | CN102600396A Traditional Chinese medicinal preparation for treating common nerve compression in lumbar vertebral column cavity caused by hyperostosis |
07/25/2012 | CN102600395A Dietary therapy product for protecting joints and preparation method thereof |
07/25/2012 | CN102600385A Lycopodium clavatum pain relieving tablet |
07/25/2012 | CN102600381A Hot-ironing bag for spur, rheumatism and osteosynthesis and preparation method for same |
07/25/2012 | CN102600377A Medicine for treatment of cervical disease and preparation method thereof |
07/25/2012 | CN102600366A Medicament for treating osteoporosis, osteoproliferation and renal failure |
07/25/2012 | CN102600338A Acanthopanax brachypus liquor for rheumatoid arthritis |
07/25/2012 | CN102600337A Traditional Chinese medicine prescription for treating gout |
07/25/2012 | CN102600328A Fracture setting hot compress traditional Chinese medicine bag |
07/25/2012 | CN102600327A Ostealgia treating capsule |
07/25/2012 | CN102600326A Medicament for treating heumatism |
07/25/2012 | CN102600324A Externally used traditional Chinese medicine for treating rheumatoid arthritis |